N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, And Composition For Transfer And Storage Of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound
申请人:Shinohata Masaaki
公开号:US20110133121A1
公开(公告)日:2011-06-09
The present invention is a method for producing an N-substituted carbamic acid ester derived from an organic amine from an organic amine, a carbonic acid derivative and a hydroxy composition containing one or more types of hydroxy compounds, wherein the organic amine, the carbonic acid derivative and the hydroxy composition are reacted using a urethane production reaction vessel provided with a condenser, a gas containing the hydroxy composition, the compound having the carbonyl group derived from the carbonic acid derivative, and an ammonia formed as a by-product in the reaction, is introduced into the condenser provided in the urethane production reaction vessel, and the hydroxy composition and the compound having the carbonyl group derived from the carbonic acid derivative are condensed, and wherein a stoichiometric ratio of a hydroxy compound contained in the condensed hydroxy composition to the condensed compound having the carbonyl group derived from the carbonic acid derivative is 1 or more, and a ratio of number of carbonyl groups (—C(═O)—) contained in the compound having the carbonyl group derived from the carbonic acid derivative and number of ammonia molecules contained in the ammonia recovered as a gas from the condenser is 1 or less.
N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, and Composition for Transfer and Storage of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound
申请人:Asahi Kasei Chemicals Corporation
公开号:US20140194650A1
公开(公告)日:2014-07-10
The present invention is a method for producing an N-substituted carbamic acid ester derived from an organic amine from an organic amine, a carbonic acid derivative and a hydroxy composition containing one or more types of hydroxy compounds, wherein the organic amine, the carbonic acid derivative and the hydroxy composition are reacted using a urethane production reaction vessel provided with a condenser, a gas containing the hydroxy composition, the compound having the carbonyl group derived from the carbonic acid derivative, and an ammonia formed as a by-product in the reaction, is introduced into the condenser provided in the urethane production reaction vessel, and the hydroxy composition and the compound having the carbonyl group derived from the carbonic acid derivative are condensed, and wherein a stoichiometric ratio of a hydroxy compound contained in the condensed hydroxy composition to the condensed compound having the carbonyl group derived from the carbonic acid derivative is 1 or more, and a ratio of number of carbonyl groups (—C(═O)—) contained in the compound having the carbonyl group derived from the carbonic acid derivative and number of ammonia molecules contained in the ammonia recovered as a gas from the condenser is 1 or less.
Novel s-triazole[1,5-a]pyrimidine derivatives represented by the general formula (I):
wherein R, and R2 may be the same or different and each represents a straight or branched alkyl group containing 1 to 6 carbon atoms, a phenyl group or a hydrogen atom, R3 represents a straight or branched alkyl group containing 1 to 6 carbon atoms or a hydrogen atom, R4 represents a straight or branched alkyl group containing 1 to 6 carbon atoms, a phenyl group or a substituted phenyl group, and R5 represents a hydrogen atom or R5 and R, together form a -(CH2)- group. The compounds have vasodilating, hypotensive and blood platelet agglutination-preventing effects, and are useful for treating diseases of circulatory organs.
A process for preparing an N-alyklaminophenol represented by the formula (III):
wherein R, represents a hydrogen atom or an alkyl group having from 1 to 6 carbon atoms; and R2 represents an alkyl group having from 1 to 6 carbon atoms, which comprises reacting an aminophenol represented by the formula (I):
wherein R1 is as defined above, with an alkyl halide represented by the formula (II):
wherein R2 is as defined above; and X represents a halogen atom, at 80°-120 °C at 3-30 kg/cm2G pressure in an autoclave in the presence of water under heat and pressure, using ammonia as an acid scavenger,
1-2 mols of alkyl halide are used per mol of alkyl group and 1-3 mols ammonia per mol compound (I).
The ammonia is preferably introduced continuously while the pH is 4-10, and with 0.05-4 parts by wt. water per wt. of aminophenol.
Utilisation de phényléthanolamines pour la préparation de médicaments agissant sur les troubles gastro-intestinaux
申请人:ELF SANOFI
公开号:EP0255415A2
公开(公告)日:1988-02-03
Utilisation d'analogues de phényléthanolamine, éventuellement substituée sur le groupe phényle par un atome d'halogène ou par un groupe alkyle ou trifluorométhyle et substituée sur le groupe amino par un groupe phénylalkyle ou phénoxyalkyle éventuellement substitué sur le noyau benzène comme principes actifs pour la préparation de médicaments pour la prophylaxie ou le traitement de troubles gastro-intestinaux associés à une contraction du muscle lisse.